Skip to Content
ON
DEMAND
Subscribe Now
News
Series
Conferences
Insights
Features
MORE
FORTUNE.COM
FORTUNE LIVE MEDIA
FORTUNE CONNECT
Search
LOGIN
Subscribe Now
Series
Pfizer CEO Albert Bourla reflects on unprecedented vaccine development
February 02, 2021 00:00 AM UTC
- Updated February 03, 2021 18:50 PM UTC
Fortune Editor-in-Chief Clifton Leaf talks with Bourla about the remarkable development process.
Sections
Health
Tags
Clifton Leaf
Pfizer
vaccine
COVID-19
coronavirus